Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V G Bain

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Alimentary Pharmacology & Therapeutics|July 31, 2007
Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disordersJ McDermid, M Chen, Y Li, et al.
Journal of Viral Hepatitis|July 3, 2004
A multicentre study of the usefulness of liver biopsy in hepatitis CV G Bain, M Bonacini, S Govindarajan, et al.
Alimentary Pharmacology & Therapeutics|January 21, 2006
Treating chronic hepatitis C with pegylated interferon alfa-2a (40 KD) and ribavirin in clinical practiceS S Lee, V G Bain, K Peltekian, et al.
Alimentary Pharmacology & Therapeutics|April 10, 2008
Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alpha-2a plus ribavirinV G Bain, S S Lee, K Peltekian, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|April 29, 1998
Postliver transplant allograft reinfection with a lamivudine-resistant strain of hepatitis B virus: long-term follow-upE M Yoshida, M M Ma, J E Davis, et al.
Journal of Clinical Pathology|July 1, 1991
Expression of intrahepatic hepatitis D viral antigen in chronic hepatitis D virus infectionJ Y Lau, L J Hansen, V G Bain, et al.
Journal of Hepatology|October 6, 2000
Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistanceK S Gutfreund, M Williams, R George, et al.
Hepatology (Baltimore, Md.)|July 1, 1999
Efficacy of interferon treatment for patients with chronic hepatitis C: comparison of response in cirrhotics, fibrotics, or nonfibroticsG T Everson, D M Jensen, J R Craig, et al.
Gut|May 20, 2006
Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapyM Sherman, E M Yoshida, M Deschenes, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|February 15, 2007
Induction versus noninduction antiviral therapy for chronic hepatitis C virus in patients with congenital coagulation disorders: a Canadian multicentre trialA Chatterjee, M G Swain, S S Lee, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Alimentary Pharmacology & Therapeutics|July 31, 2007
Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disordersJ McDermid, M Chen, Y Li, et al.
Journal of Viral Hepatitis|July 3, 2004
A multicentre study of the usefulness of liver biopsy in hepatitis CV G Bain, M Bonacini, S Govindarajan, et al.
Alimentary Pharmacology & Therapeutics|January 21, 2006
Treating chronic hepatitis C with pegylated interferon alfa-2a (40 KD) and ribavirin in clinical practiceS S Lee, V G Bain, K Peltekian, et al.
Alimentary Pharmacology & Therapeutics|April 10, 2008
Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alpha-2a plus ribavirinV G Bain, S S Lee, K Peltekian, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|April 29, 1998
Postliver transplant allograft reinfection with a lamivudine-resistant strain of hepatitis B virus: long-term follow-upE M Yoshida, M M Ma, J E Davis, et al.
Journal of Clinical Pathology|July 1, 1991
Expression of intrahepatic hepatitis D viral antigen in chronic hepatitis D virus infectionJ Y Lau, L J Hansen, V G Bain, et al.
Journal of Hepatology|October 6, 2000
Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistanceK S Gutfreund, M Williams, R George, et al.
Hepatology (Baltimore, Md.)|July 1, 1999
Efficacy of interferon treatment for patients with chronic hepatitis C: comparison of response in cirrhotics, fibrotics, or nonfibroticsG T Everson, D M Jensen, J R Craig, et al.
Gut|May 20, 2006
Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapyM Sherman, E M Yoshida, M Deschenes, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|February 15, 2007
Induction versus noninduction antiviral therapy for chronic hepatitis C virus in patients with congenital coagulation disorders: a Canadian multicentre trialA Chatterjee, M G Swain, S S Lee, et al.
Pageof 5